Astrocyte-mediated control of cerebral blood flow
[DOI] [PMC free article] [PubMed] [Google Scholar] He M, Hou J, Wang L, Zheng M, Fang T, Wang X, Xia J, 2017
Br J Pharmacol 2019;176:594-606
Carroll stresses that while these complications are rare, theyre the reason GLP-1 medications require clinician oversight rather than self-administration
Its biopharma analysts believe obesity treatment is on the cusp of moving into primary care management, and noting the rise of semaglutide drugs like Ozempic and Wegovy for weight loss in the last two years, they estimate obesity revenues to exceed $50B in the US and $75B globally by 2030
Investigating any remaining root causes: Sometimes hydrogen sulfide levels improve, but symptoms linger